Page d'accueil  |  Aide  |  Effacer
Anglais  |  Français
 Rechercher  |  Catégories  |  Titres A-Z  |  Pays  |  Comparer pays  |  Index  
Etendre sommaire
Document complet
Dérouler chapitre
Préférences

fermer ce livreAssessment of the Pharmaceutical Situation in Kenya - A Baseline Survey (HAI, WHO; 2003; 78 pages)
Afficher le documentLIST OF ABBREVIATIONS
Afficher le documentACKNOWLEDGEMENTS
Afficher le document1. EXECUTIVE SUMMARY
ouvrir ce répertoire et afficher son contenu2. INTRODUCTION
ouvrir ce répertoire et afficher son contenu3. SURVEY DESIGN AND METHODOLOGY
fermer ce répertoire4. RESULTS AND ANALYSIS
fermer ce répertoire4.1 LEVEL I CORE INDICATORS
Afficher le document4.1.1 National Medicine Policy
Afficher le document4.1.2 Legislation/regulation
Afficher le document4.1.3 Quality control of pharmaceuticals
Afficher le document4.1.4 Essential medicines list
Afficher le document4.1.5 Medicines supply system
Afficher le document4.1.6 Medicines financing
Afficher le document4.1.7 Access to essential medicines
Afficher le document4.1.8 Production
Afficher le document4.1.9 Rational use
ouvrir ce répertoire et afficher son contenu4.2 LEVEL II CORE INDICATORS
Afficher le document5. CONCLUSION
Afficher le document6. POSITIVE ASPECTS AND AREAS FOR IMPROVEMENT IDENTIFIED
Afficher le document7. SUMMARY OF RECOMMENDATIONS
ouvrir ce répertoire et afficher son contenuAPPENDICES
 

4.1.9 Rational use

• Standard treatment guidelines (STG) produced by the MOH was last reviewed in 2002.

• There is no National Medicines Formulary manual.

• There are no continuing education programs, medicines information centre or public education campaign concerning rational medicines use although there is a government department with a specific mandate to promote rational use of medicines and co-ordinate medicines use policies.

• All referral hospitals and a few general hospitals have drugs and therapeutics committees.


Interpretation:

The results from level I indicators suggest that, although the basic structures that are considered necessary for implementing a national medicine policy exists the performance of the structures is not optimal.

Recommendations:

• The KNDP needs to be revised so as to include the regulation of traditional medicines.

• Improve the capacity of the Pharmacy and Poisons Board to effectively carry out its role.

• There is a need to allocate more funds to the health sector especially to cater for medicines.**


• There is need to develop a pricing policy on medicines.

Strategies need to be developed so as to promote rational use of medicines.

• A functional National Pharmacy and Therapeutics Committee needs to be established, supported (financially and technically) and sustained.

• A functional National Medicines Management Information System/Logistics Management Information System needs to be established, supported (financially and technically) and sustained

vers la section précédentevers la section suivante

S'il vous plaît envoyez vos commentaires
Abréviations
Anglais  |  Français